WO2022081328A1 - Biased distal assemblies with locking mechanism - Google Patents
Biased distal assemblies with locking mechanism Download PDFInfo
- Publication number
- WO2022081328A1 WO2022081328A1 PCT/US2021/051923 US2021051923W WO2022081328A1 WO 2022081328 A1 WO2022081328 A1 WO 2022081328A1 US 2021051923 W US2021051923 W US 2021051923W WO 2022081328 A1 WO2022081328 A1 WO 2022081328A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- distal
- strut
- assemblies
- center portion
- closed position
- Prior art date
Links
- 230000007246 mechanism Effects 0.000 title claims abstract description 22
- 230000000712 assembly Effects 0.000 title claims description 61
- 238000000429 assembly Methods 0.000 title claims description 61
- 210000003709 heart valve Anatomy 0.000 claims abstract description 12
- 230000017531 blood circulation Effects 0.000 claims description 5
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 5
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 5
- 230000008878 coupling Effects 0.000 claims description 4
- 238000010168 coupling process Methods 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 description 15
- 230000008439 repair process Effects 0.000 description 10
- 210000004115 mitral valve Anatomy 0.000 description 9
- 238000000034 method Methods 0.000 description 7
- 206010067171 Regurgitation Diseases 0.000 description 6
- 230000002861 ventricular Effects 0.000 description 5
- 230000001746 atrial effect Effects 0.000 description 3
- 210000005246 left atrium Anatomy 0.000 description 3
- 208000005907 mitral valve insufficiency Diseases 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 210000000591 tricuspid valve Anatomy 0.000 description 3
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 210000005240 left ventricle Anatomy 0.000 description 2
- 210000003540 papillary muscle Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 210000001765 aortic valve Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 210000002073 venous valve Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/246—Devices for obstructing a leak through a native valve in a closed condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2466—Delivery devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
- A61F2220/0016—Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0041—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using additional screws, bolts, dowels or rivets, e.g. connecting screws
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0091—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements connected by a hinged linkage mechanism, e.g. of the single-bar or multi-bar linkage type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
- A61F2250/001—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting a diameter
Definitions
- the disclosed subject matter is directed to medical devices for the endovascular, percutaneous or minimally invasive surgical treatment of bodily tissues, such as tissue approximation or valve repair. More particularly, the present disclosure relates to repair of valves of the heart and venous valves.
- tissue approximation includes coapting the leaflets of the valves in a therapeutic arrangement which can then be maintained by fastening or fixing the leaflets.
- Such coaptation can be used to treat regurgitation, which commonly occurs in the mitral valve and in the tricuspid valve.
- Mitral valve regurgitation is characterized by retrograde flow from the left ventricle of a heart through an incompetent mitral valve into the left atrium.
- the mitral valve acts as a check valve to prevent flow of oxygenated blood back into the left atrium. In this way, the oxygenated blood is pumped into the aorta through the aortic valve.
- Regurgitation of the mitral valve can significantly decrease the pumping efficiency of the heart, placing the patient at risk of severe, progressive heart failure.
- Mitral valve regurgitation can result from a number of different mechanical defects in the mitral valve or the left ventricular wall.
- the valve leaflets, the valve chordae which connect the leaflets to the papillary muscles, the papillary muscles or the left ventricular wall can be damaged or otherwise dysfunctional.
- the valve annulus can be damaged, dilated, or weakened limiting the ability of the mitral valve to close adequately against the high pressures of the left ventricle.
- valve annul oplasty Treatments for mitral valve regurgitation rely on valve replacement or repair including leaflet and annulus remodeling, the latter generally referred to as valve annul oplasty.
- Another technique for mitral valve repair which relies on suturing adjacent segments of the opposed valve leaflets together is referred to as the “bow-tie” or “edge- to-edge” technique.
- the use of devices and systems should not require open chest access and, rather, be capable of being performed either endovascularly, i.e., using devices, such as a catheter, which are advanced to the heart from a point in the patient's vasculature remote from the heart.
- a fixation device i.e., valve repair clip
- Such devices and systems likewise can be useful for repair of tissues in the body other than heart valves.
- the disclosed subject matter is directed to a fixation device for treating a patient.
- a system for fixation of native leaflets of a heart valve including an implantable fixation device including a center portion defining a longitudinal axis.
- the implantable fixation device further includes a first distal assembly having a first distal strut pivotally-coupled with the center portion and a first distal element pivotally-coupled with the first distal strut.
- the first distal assembly is configured to move between a closed position with the first distal strut folded proximate the center portion and the first distal element folded proximate the first distal strut, and an extended position with the first distal strut extending distally from the center portion and the first distal element extends distally from the first distal strut.
- the implantable fixation device further includes a second distal assembly having a second distal strut pivotally- coupled with the center portion and a second distal element pivotally-coupled with the second distal strut.
- the second distal assembly is configured to move between a closed position with the second distal strut folded proximate the center portion and the second distal element folded proximate the second distal strut, and an extended position with the second distal strut extending distally from the center portion and the second distal element extending distally from the second distal strut.
- the second distal assembly is biased towards the closed position.
- the implantable fixation device further includes a first proximal element having a first gripping portion.
- the first gripping portion is moveable relative to the first distal assembly to capture native leaflet tissue therebetween.
- the implantable fixation device further includes a second proximal element having a second gripping portion.
- the second gripping portion is moveable relative to the second distal assembly to capture native leaflet tissue therebetween.
- the implantable fixation device further includes a locking mechanism configured to lock the first distal assembly and second distal assembly in a selected locked position between the closed position and the extended position.
- the center portion can include a smooth surface.
- the center portion can be configured to obstruct regurgitant blood flow between native leaflets of the heart valve.
- Each of the first and second distal assemblies can comprise a plurality of stamped metal components having at least one rivet attachment.
- Each of the first and second distal assemblies can be made of a single-piece, braided structure.
- the first and second distal assemblies can be biased towards the closed position by at least one spring.
- the at least one spring can produce between about 0.10 Ibf and 0.50 Ibf of closure force at each of the first and second distal struts measured proximate a location of coupling between the first and second distal struts and the first and second distal elements, respectively.
- the implantable fixation device can further include an actuator shaft operatively connected to the first and second distal assemblies, and the at least one spring is an axial spring operatively connected to the actuator shaft. Additionally or alternatively, the at least one spring can be a torsion spring operatively connected to at least one pivot point of each of the first and second distal assemblies. Additionally or alternatively, each of the first and second distal assemblies can include a flexural member configured to bias each of the first and second distal assemblies towards the closed position, wherein the flexural member can be made of nitinol and can include a beam structure selected from the group consisting of a slotted beam, a solid beam, and a hinged beam.
- each of the flexural members can comprise a living hinge at a pivot point of the first and second distal assemblies, respectively, with the strain-free condition set in the fully closed condition.
- each of the first and second proximal elements can be attached to the center portion.
- the first proximal element can be attached to the first distal strut and the second proximal element can be attached to the second distal strut.
- the locking mechanism can include a binding plate configured to lock each of the first and second distal assemblies when the binding plate is at an angled orientation relative to the longitudinal axis and further configured to unlock each of the first and second distal assemblies when the binding plate is at a perpendicular orientation relative to the longitudinal axis.
- the system for fixation can further include a delivery device releasably attached to the implantable fixation device, the delivery device can include an actuator rod, wherein the implantable fixation device can be releasably attached to the implantable fixation device at a distal end of the actuator rod.
- the actuator rod can be rotatable and can include a threaded fastener at the distal end thereof.
- the threaded fastener can be configured to connect to the implantable fixation device by a threaded connection. Distal movement of the actuator rod moves each of the first and second distal assemblies towards the extended position, and proximal movement of the actuator rod moves each of the first and second distal assemblies towards the closed position.
- FIG. l is a front view of an exemplary embodiment of an implantable fixation device for use in accordance with the disclosed subject matter, the implantable fixation device having distal assemblies in the extended position.
- FIGS. 2A-2C are front views of the implantable fixation device of FIG. 1, wherein the distal assemblies are in various non-extended positions.
- FIGS. 3 A-3D are front views of an alternative implantable fixation device including an axial spring.
- FIGS. 4A-C are front views of an alternative implantable fixation device including a torsion spring.
- FIGS. 5A-5D are front views of an alternative implantable fixation device having proximal elements attached to distal struts.
- FIG. 6 is a front view of the implantable fixation device of FIGS. 3A-3D and a delivery device configured for releasable attachment.
- FIG. 7 is a front view of the implantable fixation device of FIGS. 5A-5D further depicting suture lines attached to the proximal elements.
- the fixation device for use with the disclosed subject matter provides an edge-to- edge transcatheter valve repair option for patients having various conditions, including regurgitant mitral valves or tricuspid valves.
- Transcatheter (e.g., trans-septal) edge-to- edge valve repair has been established using a fixation device.
- These fixation devices generally are configured to capture and secure opposing native leaflets using two types of leaflet contacting elements. The first element is a sub-valvular element to contact the ventricular side of a native leaflet to be grasped.
- a second elastic proximal element can be lowered or moved toward the sub-valvular element and into contact with the atrial side of the native leaflet to capture the leaflet therebetween.
- the fixation device can be closed by raising or moving the sub-valvular element toward a center of the fixation device such that the leaflets are brought into coaptation, which results in a reduction in valvular regurgitation during ventricular systole.
- a covering can be provided on the sub-valvular and/or proximal element to facilitate tissue ingrowth with the captured leaflets.
- an implantable fixation device with subvalvular elements can be self-closing (/. ⁇ ., biased towards a closed position), which can have advantages for simplifying an implantation procedure.
- Self-closing sub-valvular elements can be in a final closing angle when a total leaflet resistance force and an internal self-closing force of the sub-valvular elements are equal, thus creating a final equilibrium closing angle.
- opening the angle can reduce leaflet coaptation to allow more forward blood flow, and thus reduce the possibility of a high gradient.
- leaflets are particularly vulnerable e.g., thin, friable, short, or calcified
- opening the angle can reduce forces on the leaflets and consequently reduce the probability of a leaflet tear.
- it can conversely be beneficial to selectively close the angle beyond the equilibrium closing angle For example, for valves having abnormally large gaps between leaflets, further closing the angle can reduce excessive regurgitation and improve grasping performance, thus reducing the probability of requiring additional implanted devices to sufficiently reduce regurgitation.
- valves having uneven leaflets further closing the angle can ensure the thinner of the two leaflets is sufficiently grasped. Indeed, in a purely self-closing device grasping uneven leaflets, the device will only close to the point of first resistance, such as when the thicker of two inserted leaflets is contacted, which can leave the thinner leaflet insufficiently grasped.
- a self-closing (biased closed) device can be combined with one or more additional features, such as a locking mechanism, to enable manual selection and fine-tuning of the final closed angle.
- the disclosed subject matter provided herein includes a system for fixation of native leaflets of a heart valve including an implantable fixation device including a center portion defining a longitudinal axis.
- the implantable fixation device further includes a first distal assembly having a first distal strut pivotally-coupled with the center portion and a first distal element pivotally- coupled with the first distal strut.
- the first distal assembly is configured to move between a closed position with the first distal strut folded proximate the center portion and the first distal element folded proximate the first distal strut, and an extended position with the first distal strut extending distally from the center portion and the first distal element extends distally from the first distal strut.
- the first distal assembly is biased towards the closed position.
- the implantable fixation device further includes a second distal assembly having a second distal strut pivotally-coupled with the center portion and a second distal element pivotally-coupled with the second distal strut.
- the second distal assembly is configured to move between a closed position with the second distal strut folded proximate the center portion and the second distal element folded proximate the second distal strut, and an extended position with the second distal strut extending distally from the center portion and the second distal element extending distally from the second distal strut.
- the second distal assembly is biased towards the closed position.
- the implantable fixation device further includes a first proximal element having a first gripping portion.
- the first gripping portion is moveable relative to the first distal assembly to capture native leaflet tissue therebetween.
- the implantable fixation device further includes a second proximal element having a second gripping portion.
- the second gripping portion is moveable relative to the second distal assembly to capture native leaflet tissue therebetween.
- the implantable fixation device further includes a locking mechanism configured to lock the first distal assembly and second distal assembly in a selected locked position between the closed position and the extended position.
- a system for fixation of native leaflets of a heart valve includes an implantable fixation device 102 comprising a center portion 104 defining a longitudinal axis 106. Additionally, the center portion 104 can include a smooth surface. The smooth surface finish can the provide favorable blood flow obstruction characteristics. The center portion 104 can be configured to obstruct regurgitant blood flow between native leaflets of the heart valve. Furthermore, the center portion 104 can be configured as a spacer in the valve providing a leaflet sealing surface.
- the implantable fixation device 102 further includes a first distal assembly 108 comprising a first distal strut 110 pivotally-coupled with the center portion 104 and a first distal element 112 pivotally- coupled with the first distal strut 110.
- the first distal assembly 114 is configured to move between a closed position with the first distal strut 110 folded proximate the center portion 104 and the first distal element 112 folded proximate the first distal strut 110, and an extended position with the first distal strut 110 extending distally from the center portion 104 and the first distal element 112 extending distally from the first distal strut 110.
- the first distal assembly 108 is biased towards the closed position.
- the implantable fixation device 102 further includes a second distal assembly 114 comprising a second distal strut 116 pivotally-coupled with the center portion 104 and a second distal element 118 pivotally-coupled with the second distal strut 110.
- the second distal assembly 108 is configured to move between a closed position with the second distal strut 116 folded proximate the center portion 104 and the second distal element 118 folded proximate the second distal strut 116, and an extended position with the second distal strut 116 extending distally from the center portion 104 and the second distal element 118 extending distally from the second distal strut 116.
- the second distal assembly 114 is biased towards the closed position.
- each of the first and second distal assemblies 108, 114 can comprise a plurality of stamped metal components having at least one rivet attachment 160.
- the distal elements 112, 118 and distal struts 110, 116 may be stamped metal components with various rivet attachment 160 connections, as shown for purpose of illustration and not limitation in FIG. 1.
- each of the first and second distal assemblies 108, 114 can be made of a single-piece, braided structure.
- each of the first and second distal assemblies can be made of lasercut metallic sheet structures or nitinol shape-set structures.
- the extended position can be a fully inverted position of the distal elements 112, 118 configured for delivery of the implantable fixation device 102 and further configured for complete leaflet release.
- the first and second distal assemblies 108, 114 can be configured to capture a leaflet at various positions between the closed position and the extended position, such as when the angle between the first distal element 112 and the second distal element 118 is between about 110 and 130 degrees, and preferably about 120 degrees.
- FIG. 2A depicts the first and second distal assemblies 108, 114 in the closed position
- FIGS. 2B and 2C depict the first and second distal assemblies 108, 114 in various positions between the closed and extended positions.
- the first and second distal assemblies 108, 114 can be sub-valvular elements configured to contact the ventricular side of a native leaflet to be grasped.
- the implantable fixation device includes a first proximal element 120 having a first gripping portion 122, wherein the first gripping portion 122 is moveable relative to the first distal assembly 108 to capture native leaflet tissue therebetween.
- the implantable fixation device further includes a second proximal element 124 having a second gripping portion 126, wherein the second gripping portion 126 is moveable relative to the second distal assembly 114 to capture native leaflet tissue therebetween.
- Each of the first and second proximal elements 120, 124 can be attached to the center portion 104.
- each proximal element 120, 124 can includes a plurality of friction elements, for example in rows.
- each first and second proximal element 120, 124 can be lowered or moved toward each respective first and second distal assembly 108,114 and into contact with the atrial side of the native leaflet to capture the leaflet therebetween.
- the proximal elements 120, 124 and friction elements are described further in the disclosures of the patents and applications incorporated in their entirety by reference herein.
- the implantable fixation device further includes a locking mechanism 128 configured to lock the first distal assembly 108 and second distal assembly 114 in a selected locked position between the closed position and the extended position.
- the locking mechanism 128 can include a binding plate 144 configured to lock each of the first and second distal assemblies 108, 114 when the binding plate 144 is at an angled orientation relative to the longitudinal axis 106. Further the locking mechanism 128 is configured to unlock each of the first and second distal assemblies 108, 114 when the binding plate 144 is at a perpendicular orientation relative to the longitudinal axis 106.
- the binding plate 144 when the binding plate 144 is at the perpendicular orientation, the binding plate 144 can have an internal hole that is clear of an actuator shaft 132 and when the binding plate 144 is in the angled orientation the actuator shaft is engaged and the distal assemblies 108, 114 are locked.
- the locking mechanism 128 can include a release mechanism to remotely control the binding plate 144.
- the state of the distal assemblies 108, 114 can be actuated between the positions shown in FIGs. 1-2C.
- Distal movement of the actuator shaft 132 can be arrested by the locking mechanism 128, which therefore provides a one-way lock that prevents the device from opening from more a closed position to a more open position.
- the lock can be remotely configured to an unlocked position by applying tensile force to the binding plate 144.
- a user may leave the device in an unlocked position for an entire length of a procedure, if desired.
- the user can only be unlock the device actuating the device to a more open position.
- the locking mechanism 128 can comprise a release harness, which can adjust the orientation of the binding plate 144 to a perpendicular orientation after a proximal force is applied remotely by from a user (e.g., via a suture connected to the harness).
- the binding plate 144 can have a locked default angled orientation from a leaf spring component that biases the binding plate.
- Unlocking the binding plate can unlock the binding plate 144 to a perpendicular orientation relative the longitudinal axis 106 as the leaf spring is compressed elastically.
- This unlocking force input from is applied by the user through a suture, cable, or line extending through the catheter from a handle to the locking mechanism 128.
- the lock can be only active on a distal portion of the actuator shaft 132, which can be constructed with a larger diameter than a proximal portion of the actuator shaft 132.
- Distal portion of the actuator shaft can be made with a rough surface finish such that the lock only functions on the rough surface.
- a version of the desired locking mechanism 128 is described in U.S. Pat. No. 7,604,646, however, the position of the locking mechanism is modified herein. Further, the locking mechanism 128 in accordance with the disclosed subject matter can include additional and alternative aspects, such as those described in U.S. Pat. No. 7,604,646, the entirety of the contents of which are incorporated herein by reference.
- the first and second distal assemblies 108, 114 can be biased towards the closed position by at least one spring 130.
- the at least one spring 130 can produce between about 0.10 Ibf and 0.50 Ibf of closure force at each of the first and second distal struts 110, 116 at an outer-most location of leaflet contact, which is located proximate a location of coupling between the first and second distal struts 110, 116 and the first and second distal elements 112, 118, respectively.
- the closure force can resist an anticipated maximum load of about 0.1 to 0.3 Ibf with a factor of safety of 2 to 5, or a force range of 0.2 Ibf to 1 Ibf at a location proximate the location of coupling.
- FIG. 3D depicts the first and second distal assemblies 108, 114 in the closed position wherein the at least one spring 130 is at a lowest-strain energy state.
- FIGS. 3B and 3C depict the first and second distal assemblies 108, 114 in various positions between the closed and extended positions, likewise with the at least one spring in various corresponding strain energy states.
- the implantable fixation device can further include an actuator shaft 132 operatively connected to the first and second distal assemblies 108, 114.
- the at least one spring 130 can be an axial spring 134 operatively connected to the actuator shaft 132.
- the at least one spring 130 can be a non-axial linear spring.
- the at least one spring 130 can alternatively be a constant-force spring or a nonlinear spring.
- FIGS. 4A-4C illustrate for the purpose of illustration and limitation, that the at least one spring 130 can be a torsion spring 136 operatively connected to at least one pivot point 142 of each of the first and second distal assemblies 108, 114.
- FIG. 4A depicts the first and second distal assemblies 108, 114 in the closed position wherein the torsion spring 136 is at a lowest-strain energy state.
- FIGS. 4B and 4C depict the first and second distal assemblies 108, 114 in various positions between the closed and extended positions, likewise with the torsion spring 136 in various corresponding strain energy states.
- each of the first and second distal assemblies 108, 114 can include a flexural member 138 configured to bias each of the first and second distal assemblies 108, 114 towards the closed position.
- the flexural member 138 can be made of nitinol and can comprise a beam structure selected from the group consisting of a slotted beam, a solid beam, and a hinged beam.
- each of the flexural members 138 can include a living hinge at a pivot point 142 of the first and second distal assemblies 108, 114, respectively.
- the flexural members 138 can be integral with any element of the distal assemblies 108, 114.
- the flexural members can be set to a preferred lowest-strain energy configuration when the distal assemblies 108, 114 are in the closed position by means of shape setting nitinol .
- strain energy can be at a lowest-strain energy state when the distal assemblies are fully closed.
- the biasing mechanism can have an additional lowest-strain energy state when the distal assemblies are fully extended such the that the distal assemblies can also be biased to the extended position.
- the distal assemblies can be biased to the extended position during delivery, and as the distal assemblies move towards the closed position, the bias can switch to the closed position.
- the first proximal element 120 can be attached to the first distal strut 110 and the second proximal element 124 can be attached to the second distal strut 116. Attachment of the proximal element to the distal strut can enable the movement of the distal strut and the proximal element together, which can improve the ability to capture leaflets at relatively open positions of the distal assembly 108, such as the position shown in FIG. 2C. As shown, FIG. 5A depicts the first and second distal assemblies 108, 114 in the closed position, FIG. 5D depicts the first and second assemblies 108, 114 in the extended position and FIGS. 5B- 5C depicts the first and second assemblies 108, 114 in various positions between the closed and extended positions.
- FIG. 6 depicts, for the purpose of illustration and not limitation, that the system for fixation can include a delivery device 146 releasably attached to the implantable fixation device 102.
- the delivery device 146 can include an actuator rod 148, wherein the implantable fixation device 102 can be releasably attached to the implantable fixation device 102 at a distal end 150 of the actuator rod.
- the actuator rod 148 can be rotatable and comprise a threaded fastener 152 at the distal end 150 thereof.
- the threaded fastener 152 can be configured to connect to the implantable fixation device 102 by a threaded connection.
- distal movement of the actuator rod 148 can move each of the first and second distal assemblies 108, 114 towards the extended position, and proximal movement of the actuator rod 148 can move each of the first and second distal assemblies 108, 114 towards the closed position.
- each of the first and second proximal elements 120, 124 can be biased toward each respective first and second distal assembly 108, 114.
- each proximal element 120, 124 Prior to leaflet capture, each proximal element 120, 124 can be moved inwardly toward the longitudinal axis, and, as depicted, held with the aid of one or more proximal element lines 156.
- the proximal element lines 156 can be in the form of sutures, wires, rods, cables, polymeric lines, or other suitable structures.
- the one or more proximal element lines 156 can be operatively connected with the first and second proximal elements 120, 124 in a variety of ways, such as by being threaded through loops (not shown) disposed on the first and second proximal elements 120, 124.
- a first proximal element line can be connected to the first proximal element 120 and a second proximal element line can be connected to the second proximal element 124.
- the proximal element lines 156 can lower each first and second proximal element 120, 124 toward each respective first and second distal assembly 108, 114 and into contact with the atrial side of the native leaflet to capture the leaflet therebetween.
- the proximal element lines 156 are described further in the disclosures of the patents and applications incorporated in their entirety by reference herein.
- the embodiments illustrated herein are adapted for repair of a heart valve, such as a mitral valve or a tricuspid valve, using an antegrade approach from a patient’s left or right atrium.
- imaging and various tests can be performed to anticipate and diagnose a patient’s individual circumstances and assist a physician in selecting the locked position.
- the physician can selectively lock the distal assemblies 108, 114 in the closed position or at an angle of about 10-20 degrees between the first distal element 112 and the second distal element 118.
- a physician observes significant obstruction to forward flow through the valve being treated which is termed valve stenosis and characterized by a high pressure gradient across the valve, the physician can elect lock the device at a wider angle of about 30-45 degrees.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Prostheses (AREA)
Abstract
System for fixation of native leaflets of a heart valve including an implantable fixation device including a center portion defining a longitudinal axis. The implantable fixation device further includes a first distal assembly having a first distal strut pivotally-coupled with the center portion and a first distal element pivotally-coupled with the first distal strut. The first distal assembly is configured to move between a closed position and an extended position. The implantable fixation device further includes a second distal assembly having a second distal strut pivotally-coupled with the center portion and a second distal element pivotally-coupled with the second distal strut. The second distal assembly is configured to move between a closed position and an extended position. The implantable fixation device further includes a locking mechanism configured to lock the first distal assembly and second distal assembly in a selected locked position between the closed position and the extended position.
Description
BIASED DISTAL ASSEMBLIES WITH LOCKING MECHANISM
Cross-Reference to Related Applications
This application claims priority to United States Provisional Application Serial No. 63/092,110 filed October 15, 2020, the contents of which are hereby incorporated by reference in its entirety.
Field of Disclosed Subject Matter
The disclosed subject matter is directed to medical devices for the endovascular, percutaneous or minimally invasive surgical treatment of bodily tissues, such as tissue approximation or valve repair. More particularly, the present disclosure relates to repair of valves of the heart and venous valves.
Surgical repair of bodily tissues can involve tissue approximation and fastening of such tissues in the approximated arrangement. When repairing valves, tissue approximation includes coapting the leaflets of the valves in a therapeutic arrangement which can then be maintained by fastening or fixing the leaflets. Such coaptation can be used to treat regurgitation, which commonly occurs in the mitral valve and in the tricuspid valve.
Mitral valve regurgitation is characterized by retrograde flow from the left ventricle of a heart through an incompetent mitral valve into the left atrium. During a normal cycle of heart contraction (systole), the mitral valve acts as a check valve to prevent flow of oxygenated blood back into the left atrium. In this way, the oxygenated blood is pumped into the aorta through the aortic valve. Regurgitation of the mitral valve can significantly decrease the pumping efficiency of the heart, placing the patient at risk of severe, progressive heart failure.
Mitral valve regurgitation can result from a number of different mechanical defects in the mitral valve or the left ventricular wall. The valve leaflets, the valve chordae which connect the leaflets to the papillary muscles, the papillary muscles or the left ventricular wall can be damaged or otherwise dysfunctional. Commonly, the valve annulus can be damaged, dilated, or weakened limiting the ability of the mitral valve to close adequately against the high pressures of the left ventricle.
Description of Related Art
Treatments for mitral valve regurgitation rely on valve replacement or repair including leaflet and annulus remodeling, the latter generally referred to as valve annul oplasty. Another technique for mitral valve repair, which relies on suturing adjacent
segments of the opposed valve leaflets together is referred to as the “bow-tie” or “edge- to-edge” technique. Preferably, the use of devices and systems should not require open chest access and, rather, be capable of being performed either endovascularly, i.e., using devices, such as a catheter, which are advanced to the heart from a point in the patient's vasculature remote from the heart. Furthermore, such devices and systems should allow for repositioning and optional removal of a fixation device (i.e., valve repair clip) prior to fixation to ensure optimal placement. Such devices and systems likewise can be useful for repair of tissues in the body other than heart valves.
Summary
The purpose and advantages of the disclosed subject matter will be set forth in and apparent from the description that follows, as well as will be learned by practice of the disclosed subject matter. Additional advantages of the disclosed subject matter will be realized and attained by the methods and systems particularly pointed out in the written description and claims hereof, as well as from the appended drawings.
To achieve these and other advantages and in accordance with the purpose of the disclosed subject matter, as embodied and broadly described, the disclosed subject matter is directed to a fixation device for treating a patient.
In accordance with the disclosed subject matter, a system for fixation of native leaflets of a heart valve including an implantable fixation device including a center portion defining a longitudinal axis. The implantable fixation device further includes a first distal assembly having a first distal strut pivotally-coupled with the center portion and a first distal element pivotally-coupled with the first distal strut. The first distal assembly is configured to move between a closed position with the first distal strut folded proximate the center portion and the first distal element folded proximate the first distal strut, and an extended position with the first distal strut extending distally from the center portion and the first distal element extends distally from the first distal strut. The first distal assembly is biased towards the closed position. The implantable fixation device further includes a second distal assembly having a second distal strut pivotally- coupled with the center portion and a second distal element pivotally-coupled with the second distal strut. The second distal assembly is configured to move between a closed position with the second distal strut folded proximate the center portion and the second distal element folded proximate the second distal strut, and an extended position with the second distal strut extending distally from the center portion and the second distal
element extending distally from the second distal strut. The second distal assembly is biased towards the closed position.
The implantable fixation device further includes a first proximal element having a first gripping portion. The first gripping portion is moveable relative to the first distal assembly to capture native leaflet tissue therebetween. The implantable fixation device further includes a second proximal element having a second gripping portion. The second gripping portion is moveable relative to the second distal assembly to capture native leaflet tissue therebetween. The implantable fixation device further includes a locking mechanism configured to lock the first distal assembly and second distal assembly in a selected locked position between the closed position and the extended position.
In accordance with the disclosed subject matter, the center portion can include a smooth surface. The center portion can be configured to obstruct regurgitant blood flow between native leaflets of the heart valve. Each of the first and second distal assemblies can comprise a plurality of stamped metal components having at least one rivet attachment. Each of the first and second distal assemblies can be made of a single-piece, braided structure. The first and second distal assemblies can be biased towards the closed position by at least one spring. The at least one spring can produce between about 0.10 Ibf and 0.50 Ibf of closure force at each of the first and second distal struts measured proximate a location of coupling between the first and second distal struts and the first and second distal elements, respectively. The implantable fixation device can further include an actuator shaft operatively connected to the first and second distal assemblies, and the at least one spring is an axial spring operatively connected to the actuator shaft. Additionally or alternatively, the at least one spring can be a torsion spring operatively connected to at least one pivot point of each of the first and second distal assemblies. Additionally or alternatively, each of the first and second distal assemblies can include a flexural member configured to bias each of the first and second distal assemblies towards the closed position, wherein the flexural member can be made of nitinol and can include a beam structure selected from the group consisting of a slotted beam, a solid beam, and a hinged beam. Further, each of the flexural members can comprise a living hinge at a pivot point of the first and second distal assemblies, respectively, with the strain-free condition set in the fully closed condition.
Further, each of the first and second proximal elements can be attached to the center portion. Alternatively, the first proximal element can be attached to the first distal strut and the second proximal element can be attached to the second distal strut.
In accordance with another aspect of the disclosed subject matter, the locking mechanism can include a binding plate configured to lock each of the first and second distal assemblies when the binding plate is at an angled orientation relative to the longitudinal axis and further configured to unlock each of the first and second distal assemblies when the binding plate is at a perpendicular orientation relative to the longitudinal axis.
Additionally, the system for fixation can further include a delivery device releasably attached to the implantable fixation device, the delivery device can include an actuator rod, wherein the implantable fixation device can be releasably attached to the implantable fixation device at a distal end of the actuator rod. The actuator rod can be rotatable and can include a threaded fastener at the distal end thereof. The threaded fastener can be configured to connect to the implantable fixation device by a threaded connection. Distal movement of the actuator rod moves each of the first and second distal assemblies towards the extended position, and proximal movement of the actuator rod moves each of the first and second distal assemblies towards the closed position.
Brief Description of the Figures
FIG. l is a front view of an exemplary embodiment of an implantable fixation device for use in accordance with the disclosed subject matter, the implantable fixation device having distal assemblies in the extended position.
FIGS. 2A-2C are front views of the implantable fixation device of FIG. 1, wherein the distal assemblies are in various non-extended positions.
FIGS. 3 A-3D are front views of an alternative implantable fixation device including an axial spring.
FIGS. 4A-C are front views of an alternative implantable fixation device including a torsion spring.
FIGS. 5A-5D are front views of an alternative implantable fixation device having proximal elements attached to distal struts.
FIG. 6 is a front view of the implantable fixation device of FIGS. 3A-3D and a delivery device configured for releasable attachment.
FIG. 7 is a front view of the implantable fixation device of FIGS. 5A-5D further depicting suture lines attached to the proximal elements.
Detailed Description
Reference will now be made in detail to the various exemplary embodiments of the disclosed subject matter, exemplary embodiments of which are illustrated in the accompanying drawings.
The fixation device for use with the disclosed subject matter provides an edge-to- edge transcatheter valve repair option for patients having various conditions, including regurgitant mitral valves or tricuspid valves. Transcatheter (e.g., trans-septal) edge-to- edge valve repair has been established using a fixation device. These fixation devices generally are configured to capture and secure opposing native leaflets using two types of leaflet contacting elements. The first element is a sub-valvular element to contact the ventricular side of a native leaflet to be grasped. With the sub-valvular element positioned underneath to stabilize the native leaflet in a beating heart, a second elastic proximal element can be lowered or moved toward the sub-valvular element and into contact with the atrial side of the native leaflet to capture the leaflet therebetween. Once each native leaflet is captured by a respective sub-valvular and proximal element, the fixation device can be closed by raising or moving the sub-valvular element toward a center of the fixation device such that the leaflets are brought into coaptation, which results in a reduction in valvular regurgitation during ventricular systole. Furthermore, a covering can be provided on the sub-valvular and/or proximal element to facilitate tissue ingrowth with the captured leaflets.
Additional details of exemplary fixation devices in accordance with the disclosed subject matter are set forth below. Furthermore, a number of patents and publications disclose additional details and aspects of related fixation devices and operations. See for example, U.S. Pat. No. 7,226,467 to Lucatero et al.; U.S. Pat. No. 7,563,267 to Goldfarb et al.; U.S. Pat. No. 7,655,015 to Goldfarb et al.; U.S. Pat. No. 7,736,388 to Goldfarb et al.; U.S. Pat. No. 7,811,296 to Goldfarb et al.; U.S. Pat. No. 8,057,493 to Goldfarb et al.; U.S. Pat. No. 8,303,608 to Goldfarb et al.; U.S. Pat. No. 8,500,761 to Goldfarb et al.;
U.S. Pat. No. 8,734,505 to Goldfarb et al.; U.S. Pat. No. 8,740,920 to Goldfarb et al.;
U.S. Pat. No. 9,510,829 to Goldfarb et al.; U.S. Pat. No. 7,635,329 to Goldfarb et al.;
U.S. Patent Application Publication No. 2017/0042546 to Goldfarb et al.; U.S. Patent
Application Publication No. 2017/0239048 to Goldfarb et al.; U.S. Patent Application Publication No. 2018/0325671 to Abunassar et al., the entirety of the contents of each of these patents and published applications is incorporated herein by reference.
In fixing leaflets of a heart valve, an implantable fixation device with subvalvular elements can be self-closing (/.< ., biased towards a closed position), which can have advantages for simplifying an implantation procedure. Self-closing sub-valvular elements can be in a final closing angle when a total leaflet resistance force and an internal self-closing force of the sub-valvular elements are equal, thus creating a final equilibrium closing angle. In various circumstances, there are advantages to manually adjusting and fine tuning the final closing angle, thereby modifying the angle to be more open or closed as compared to final equilibrium closing angle. This can allow a user to improve performance of the implantable fixation device in certain situations (e.g., in patients having certain abnormal valve anatomies). When the closing angle is modified, this allows for a direct impact on the tradeoff between regurgitation reduction and diastolic pressure gradient, which is associated with valve stenosis.
In some situations, it can be beneficial to selectively open the angle from the equilibrium closing angle. For example, for relatively small valves, opening the angle can reduce leaflet coaptation to allow more forward blood flow, and thus reduce the possibility of a high gradient. Likewise, when leaflets are particularly vulnerable e.g., thin, friable, short, or calcified) opening the angle can reduce forces on the leaflets and consequently reduce the probability of a leaflet tear. Alternatively, in other situations and circumstances, it can conversely be beneficial to selectively close the angle beyond the equilibrium closing angle. For example, for valves having abnormally large gaps between leaflets, further closing the angle can reduce excessive regurgitation and improve grasping performance, thus reducing the probability of requiring additional implanted devices to sufficiently reduce regurgitation. Likewise, for valves having uneven leaflets, further closing the angle can ensure the thinner of the two leaflets is sufficiently grasped. Indeed, in a purely self-closing device grasping uneven leaflets, the device will only close to the point of first resistance, such as when the thicker of two inserted leaflets is contacted, which can leave the thinner leaflet insufficiently grasped.
Accordingly, a self-closing (biased closed) device can be combined with one or more additional features, such as a locking mechanism, to enable manual selection and fine-tuning of the final closed angle.
Generally, and as set forth in greater detail below, the disclosed subject matter provided herein includes a system for fixation of native leaflets of a heart valve including an implantable fixation device including a center portion defining a longitudinal axis. The implantable fixation device further includes a first distal assembly having a first
distal strut pivotally-coupled with the center portion and a first distal element pivotally- coupled with the first distal strut. The first distal assembly is configured to move between a closed position with the first distal strut folded proximate the center portion and the first distal element folded proximate the first distal strut, and an extended position with the first distal strut extending distally from the center portion and the first distal element extends distally from the first distal strut. The first distal assembly is biased towards the closed position. The implantable fixation device further includes a second distal assembly having a second distal strut pivotally-coupled with the center portion and a second distal element pivotally-coupled with the second distal strut. The second distal assembly is configured to move between a closed position with the second distal strut folded proximate the center portion and the second distal element folded proximate the second distal strut, and an extended position with the second distal strut extending distally from the center portion and the second distal element extending distally from the second distal strut. The second distal assembly is biased towards the closed position.
The implantable fixation device further includes a first proximal element having a first gripping portion. The first gripping portion is moveable relative to the first distal assembly to capture native leaflet tissue therebetween. Likewise, the implantable fixation device further includes a second proximal element having a second gripping portion. Similarly, the second gripping portion is moveable relative to the second distal assembly to capture native leaflet tissue therebetween. Additionally, the implantable fixation device further includes a locking mechanism configured to lock the first distal assembly and second distal assembly in a selected locked position between the closed position and the extended position.
Referring to FIGS. 1 and 2A-2C, for the purpose of illustration and not limitation, a system for fixation of native leaflets of a heart valve includes an implantable fixation device 102 comprising a center portion 104 defining a longitudinal axis 106. Additionally, the center portion 104 can include a smooth surface. The smooth surface finish can the provide favorable blood flow obstruction characteristics. The center portion 104 can be configured to obstruct regurgitant blood flow between native leaflets of the heart valve. Furthermore, the center portion 104 can be configured as a spacer in the valve providing a leaflet sealing surface.
In accordance with the disclosed subject matter, the implantable fixation device 102 further includes a first distal assembly 108 comprising a first distal strut 110
pivotally-coupled with the center portion 104 and a first distal element 112 pivotally- coupled with the first distal strut 110. The first distal assembly 114 is configured to move between a closed position with the first distal strut 110 folded proximate the center portion 104 and the first distal element 112 folded proximate the first distal strut 110, and an extended position with the first distal strut 110 extending distally from the center portion 104 and the first distal element 112 extending distally from the first distal strut 110. The first distal assembly 108 is biased towards the closed position. The implantable fixation device 102 further includes a second distal assembly 114 comprising a second distal strut 116 pivotally-coupled with the center portion 104 and a second distal element 118 pivotally-coupled with the second distal strut 110. The second distal assembly 108 is configured to move between a closed position with the second distal strut 116 folded proximate the center portion 104 and the second distal element 118 folded proximate the second distal strut 116, and an extended position with the second distal strut 116 extending distally from the center portion 104 and the second distal element 118 extending distally from the second distal strut 116. Furthermore, the second distal assembly 114 is biased towards the closed position.
As embodied herein, each of the first and second distal assemblies 108, 114 can comprise a plurality of stamped metal components having at least one rivet attachment 160. For example, the distal elements 112, 118 and distal struts 110, 116 may be stamped metal components with various rivet attachment 160 connections, as shown for purpose of illustration and not limitation in FIG. 1. Additionally or alternatively, each of the first and second distal assemblies 108, 114 can be made of a single-piece, braided structure. As another example, each of the first and second distal assemblies can be made of lasercut metallic sheet structures or nitinol shape-set structures.
The extended position can be a fully inverted position of the distal elements 112, 118 configured for delivery of the implantable fixation device 102 and further configured for complete leaflet release. The first and second distal assemblies 108, 114 can be configured to capture a leaflet at various positions between the closed position and the extended position, such as when the angle between the first distal element 112 and the second distal element 118 is between about 110 and 130 degrees, and preferably about 120 degrees. FIG. 2A depicts the first and second distal assemblies 108, 114 in the closed position, and FIGS. 2B and 2C depict the first and second distal assemblies 108, 114 in various positions between the closed and extended positions. The first and second
distal assemblies 108, 114 can be sub-valvular elements configured to contact the ventricular side of a native leaflet to be grasped.
In accordance with the disclosed subject matter, and with continued reference to FIG. 1, the implantable fixation device includes a first proximal element 120 having a first gripping portion 122, wherein the first gripping portion 122 is moveable relative to the first distal assembly 108 to capture native leaflet tissue therebetween. Likewise, the implantable fixation device further includes a second proximal element 124 having a second gripping portion 126, wherein the second gripping portion 126 is moveable relative to the second distal assembly 114 to capture native leaflet tissue therebetween. Each of the first and second proximal elements 120, 124 can be attached to the center portion 104. As embodied herein, each proximal element 120, 124 can includes a plurality of friction elements, for example in rows. The friction elements can allow for improved tissue engagement during leaflet capture. In leaflet capture, each first and second proximal element 120, 124 can be lowered or moved toward each respective first and second distal assembly 108,114 and into contact with the atrial side of the native leaflet to capture the leaflet therebetween. The proximal elements 120, 124 and friction elements are described further in the disclosures of the patents and applications incorporated in their entirety by reference herein.
The implantable fixation device, as depicted, further includes a locking mechanism 128 configured to lock the first distal assembly 108 and second distal assembly 114 in a selected locked position between the closed position and the extended position. As shown, and for purpose of illustration and not limitation, the locking mechanism 128 can include a binding plate 144 configured to lock each of the first and second distal assemblies 108, 114 when the binding plate 144 is at an angled orientation relative to the longitudinal axis 106. Further the locking mechanism 128 is configured to unlock each of the first and second distal assemblies 108, 114 when the binding plate 144 is at a perpendicular orientation relative to the longitudinal axis 106. For example, when the binding plate 144 is at the perpendicular orientation, the binding plate 144 can have an internal hole that is clear of an actuator shaft 132 and when the binding plate 144 is in the angled orientation the actuator shaft is engaged and the distal assemblies 108, 114 are locked. Additionally, the locking mechanism 128 can include a release mechanism to remotely control the binding plate 144. The state of the distal assemblies 108, 114 can be actuated between the positions shown in FIGs. 1-2C. Distal movement of the actuator shaft 132 can be arrested by the locking mechanism 128, which therefore
provides a one-way lock that prevents the device from opening from more a closed position to a more open position. During a procedure, the lock can be remotely configured to an unlocked position by applying tensile force to the binding plate 144. A user may leave the device in an unlocked position for an entire length of a procedure, if desired. Alternatively, the user can only be unlock the device actuating the device to a more open position. As embodied herein, the locking mechanism 128 can comprise a release harness, which can adjust the orientation of the binding plate 144 to a perpendicular orientation after a proximal force is applied remotely by from a user (e.g., via a suture connected to the harness). The binding plate 144 can have a locked default angled orientation from a leaf spring component that biases the binding plate. Unlocking the binding plate can unlock the binding plate 144 to a perpendicular orientation relative the longitudinal axis 106 as the leaf spring is compressed elastically. This unlocking force input from is applied by the user through a suture, cable, or line extending through the catheter from a handle to the locking mechanism 128. For simplicity, the lock can be only active on a distal portion of the actuator shaft 132, which can be constructed with a larger diameter than a proximal portion of the actuator shaft 132. Distal portion of the actuator shaft can be made with a rough surface finish such that the lock only functions on the rough surface. A version of the desired locking mechanism 128 is described in U.S. Pat. No. 7,604,646, however, the position of the locking mechanism is modified herein. Further, the locking mechanism 128 in accordance with the disclosed subject matter can include additional and alternative aspects, such as those described in U.S. Pat. No. 7,604,646, the entirety of the contents of which are incorporated herein by reference.
Referring to FIGS. 3A-3D, for illustration and not limitation, the first and second distal assemblies 108, 114 can be biased towards the closed position by at least one spring 130. The at least one spring 130 can produce between about 0.10 Ibf and 0.50 Ibf of closure force at each of the first and second distal struts 110, 116 at an outer-most location of leaflet contact, which is located proximate a location of coupling between the first and second distal struts 110, 116 and the first and second distal elements 112, 118, respectively. Furthermore, the closure force can resist an anticipated maximum load of about 0.1 to 0.3 Ibf with a factor of safety of 2 to 5, or a force range of 0.2 Ibf to 1 Ibf at a location proximate the location of coupling. FIG. 3D depicts the first and second distal assemblies 108, 114 in the closed position wherein the at least one spring 130 is at a lowest-strain energy state. FIGS. 3B and 3C depict the first and second distal assemblies 108, 114 in various positions between the closed and extended positions, likewise with
the at least one spring in various corresponding strain energy states. Additionally, the implantable fixation device can further include an actuator shaft 132 operatively connected to the first and second distal assemblies 108, 114. Further, and as disclosed herein, the at least one spring 130 can be an axial spring 134 operatively connected to the actuator shaft 132. Alternatively, the at least one spring 130 can be a non-axial linear spring. The at least one spring 130 can alternatively be a constant-force spring or a nonlinear spring.
In accordance with the disclosed subject matter, FIGS. 4A-4C illustrate for the purpose of illustration and limitation, that the at least one spring 130 can be a torsion spring 136 operatively connected to at least one pivot point 142 of each of the first and second distal assemblies 108, 114. FIG. 4A depicts the first and second distal assemblies 108, 114 in the closed position wherein the torsion spring 136 is at a lowest-strain energy state. FIGS. 4B and 4C depict the first and second distal assemblies 108, 114 in various positions between the closed and extended positions, likewise with the torsion spring 136 in various corresponding strain energy states.
Additionally or alternatively, each of the first and second distal assemblies 108, 114 can include a flexural member 138 configured to bias each of the first and second distal assemblies 108, 114 towards the closed position. The flexural member 138 can be made of nitinol and can comprise a beam structure selected from the group consisting of a slotted beam, a solid beam, and a hinged beam. Furthermore, each of the flexural members 138 can include a living hinge at a pivot point 142 of the first and second distal assemblies 108, 114, respectively. The flexural members 138 can be integral with any element of the distal assemblies 108, 114. The flexural members can be set to a preferred lowest-strain energy configuration when the distal assemblies 108, 114 are in the closed position by means of shape setting nitinol .
For any biasing mechanism of the disclosed subject matter (e.g., the spring or flexural members), strain energy can be at a lowest-strain energy state when the distal assemblies are fully closed. Further, the biasing mechanism can have an additional lowest-strain energy state when the distal assemblies are fully extended such the that the distal assemblies can also be biased to the extended position. For example, the distal assemblies can be biased to the extended position during delivery, and as the distal assemblies move towards the closed position, the bias can switch to the closed position.
In accordance with another embodiment of the disclosed subject matter, and as shown in FIGS. 5A-D for the purpose of illustration and not limitation, the first proximal
element 120 can be attached to the first distal strut 110 and the second proximal element 124 can be attached to the second distal strut 116. Attachment of the proximal element to the distal strut can enable the movement of the distal strut and the proximal element together, which can improve the ability to capture leaflets at relatively open positions of the distal assembly 108, such as the position shown in FIG. 2C. As shown, FIG. 5A depicts the first and second distal assemblies 108, 114 in the closed position, FIG. 5D depicts the first and second assemblies 108, 114 in the extended position and FIGS. 5B- 5C depicts the first and second assemblies 108, 114 in various positions between the closed and extended positions.
In accordance with an additional aspect of the subject matter disclosed herein, FIG. 6 depicts, for the purpose of illustration and not limitation, that the system for fixation can include a delivery device 146 releasably attached to the implantable fixation device 102. As shown, the delivery device 146 can include an actuator rod 148, wherein the implantable fixation device 102 can be releasably attached to the implantable fixation device 102 at a distal end 150 of the actuator rod. Furthermore, the actuator rod 148 can be rotatable and comprise a threaded fastener 152 at the distal end 150 thereof. The threaded fastener 152 can be configured to connect to the implantable fixation device 102 by a threaded connection. Furthermore, distal movement of the actuator rod 148 can move each of the first and second distal assemblies 108, 114 towards the extended position, and proximal movement of the actuator rod 148 can move each of the first and second distal assemblies 108, 114 towards the closed position.
In accordance with a further aspect of the disclosed subject matter, and as further embodied herein in FIG. 7, each of the first and second proximal elements 120, 124 can be biased toward each respective first and second distal assembly 108, 114. Prior to leaflet capture, each proximal element 120, 124 can be moved inwardly toward the longitudinal axis, and, as depicted, held with the aid of one or more proximal element lines 156. The proximal element lines 156 can be in the form of sutures, wires, rods, cables, polymeric lines, or other suitable structures. Furthermore, the one or more proximal element lines 156 can be operatively connected with the first and second proximal elements 120, 124 in a variety of ways, such as by being threaded through loops (not shown) disposed on the first and second proximal elements 120, 124. For purpose of illustration and not limitation, a first proximal element line can be connected to the first proximal element 120 and a second proximal element line can be connected to the second proximal element 124. In leaflet capture, the proximal element lines 156 can
lower each first and second proximal element 120, 124 toward each respective first and second distal assembly 108, 114 and into contact with the atrial side of the native leaflet to capture the leaflet therebetween. The proximal element lines 156 are described further in the disclosures of the patents and applications incorporated in their entirety by reference herein.
The embodiments illustrated herein are adapted for repair of a heart valve, such as a mitral valve or a tricuspid valve, using an antegrade approach from a patient’s left or right atrium. Prior to a procedure, imaging and various tests can be performed to anticipate and diagnose a patient’s individual circumstances and assist a physician in selecting the locked position. For example, when a patient is exhibiting severe backflow, the physician can selectively lock the distal assemblies 108, 114 in the closed position or at an angle of about 10-20 degrees between the first distal element 112 and the second distal element 118. Conversely, when a physician observes significant obstruction to forward flow through the valve being treated, which is termed valve stenosis and characterized by a high pressure gradient across the valve, the physician can elect lock the device at a wider angle of about 30-45 degrees.
While the disclosed subject matter is described herein in terms of certain preferred embodiments for purpose of illustration and not limitation, those skilled in the art will recognize that various modifications and improvements can be made to the disclosed subject matter without departing from the scope thereof. Moreover, although individual features of one embodiment of the disclosed subject matter can be discussed herein or shown in the drawings of one embodiment and not in other embodiments, it should be readily apparent that individual features of one embodiment can be combined with one or more features of another embodiment or features from a plurality of embodiments.
In addition to the specific embodiments claimed below, the disclosed subject matter is also directed to other embodiments having any other possible combination of the dependent features claimed below and those disclosed above. As such, the particular features presented in the dependent claims and disclosed above can be combined with each other in other possible combinations. Thus, the foregoing description of specific embodiments of the disclosed subject matter has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the disclosed subject matter to those embodiments disclosed.
It will be apparent to those skilled in the art that various modifications and variations can be made in the system of the disclosed subject matter without departing from the spirit or scope of the disclosed subject matter. Thus, it is intended that the disclosed subject matter include modifications and variations that are within the scope of the appended claims and their equivalents.
Claims
1. A system for fixation of native leaflets of a heart valve comprising: an implantable fixation device comprising: a center portion defining a longitudinal axis; a first distal assembly comprising a first distal strut pivotally-coupled with the center portion and a first distal element pivotally-coupled with the first distal strut, the first distal assembly configured to move between a closed position with the first distal strut folded proximate the center portion and the first distal element folded proximate the first distal strut, and an extended position with the first distal strut extending distally from the center portion and the first distal element extending distally from the first distal strut, wherein the first distal assembly is biased towards the closed position; a second distal assembly comprising a second distal strut pivotally- coupled with the center portion and a second distal element pivotally-coupled with the second distal strut, the second distal assembly configured to move between a closed position with the second distal strut folded proximate the center portion and the second distal element folded proximate the second distal strut, and an extended position with the second distal strut extending distally from the center portion and the second distal element extending distally from the second distal strut, wherein the second distal assembly is biased towards the closed position; a first proximal element having a first gripping portion, the first gripping portion being moveable relative to the first distal assembly to capture native leaflet tissue therebetween; a second proximal element having a second gripping portion, the second gripping portion being moveable relative to the second distal assembly to capture native leaflet tissue therebetween; and a locking mechanism configured to lock the first distal assembly and second distal assembly in a selected locked position between the closed position and the extended position.
2. The system of claim 1, wherein the center portion comprises a smooth surface.
3. The system of claim 1, wherein the center portion is configured to obstruct regurgitant blood flow between native leaflets of the heart valve.
4. The system of claim 1, wherein each of the first and second distal assemblies comprises a plurality of stamped metal components having at least one rivet attachment.
5. The system of claim 1, wherein each of the first and second distal assemblies is made of a single-piece, braided structure.
6. The system of claim 1, wherein the first and second distal assemblies are biased towards the closed position by at least one spring.
7. The system of claim 6, wherein the at least one spring produces between about 0.10 Ibf and 0.50 Ibf of closure force at each of the first and second distal struts, measured proximate a location of coupling between the first and second distal struts and the first and second distal elements.
8. The system of claim 6, wherein the implantable fixation device further comprises an actuator shaft operatively connected to the first and second distal assemblies, and the at least one spring is an axial spring operatively connected to the actuator shaft.
9. The system of claim 6, wherein the at least one spring is a torsion spring operatively connected to at least one pivot point of each of the first and second distal assemblies.
10. The system of claim 1, wherein each of the first and second distal assemblies comprises a flexural member configured to bias each of the first and second distal assemblies towards the closed position, wherein the flexural member is made of nitinol and comprises a beam structure selected from the group consisting of a slotted beam, a solid beam, and a hinged beam.
11. The system of claim 10, wherein each of the flexural members comprises a living hinge at a pivot point of the first and second distal assemblies, respectively.
12. The system of claim 1, wherein each of the first and second proximal elements is attached to the center portion.
13. The system of claim 1, wherein the first proximal element is attached to the first distal strut and the second proximal element is attached to the second distal strut.
14. The system of claim 1, wherein the locking mechanism comprises a binding plate configured to lock each of the first and second distal assemblies when the binding plate is at an angled orientation relative to the longitudinal axis and further configured to unlock each of the first and second distal assemblies when the binding plate is at a perpendicular orientation relative to the longitudinal axis.
15. The system of claim 1, further comprising a delivery device releasably attached to the implantable fixation device, the delivery device comprising an actuator rod, wherein the implantable fixation device is releasably attached to the implantable fixation device at a distal end of the actuator rod.
16. The system of claim 15, wherein the actuator rod is rotatable and comprises a threaded fastener at the distal end thereof, the threaded fastener configured to connect to the implantable fixation device by a threaded connection.
17. The system of claim 15, wherein distal movement of the actuator rod moves each of the first and second distal assemblies towards the extended position, and proximal movement of the actuator rod moves each of the first and second distal assemblies towards the closed position.
17
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21791562.8A EP4196054A1 (en) | 2020-10-15 | 2021-09-24 | Biased distal assemblies with locking mechanism |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063092110P | 2020-10-15 | 2020-10-15 | |
US63/092,110 | 2020-10-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022081328A1 true WO2022081328A1 (en) | 2022-04-21 |
Family
ID=78179549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2021/051923 WO2022081328A1 (en) | 2020-10-15 | 2021-09-24 | Biased distal assemblies with locking mechanism |
Country Status (3)
Country | Link |
---|---|
US (2) | US12121439B2 (en) |
EP (1) | EP4196054A1 (en) |
WO (1) | WO2022081328A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN119700378A (en) | 2018-04-24 | 2025-03-28 | 拉古维尔·巴苏德 | Retrievable tissue grasping device, spacer, prosthetic valve and related methods |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7226467B2 (en) | 1999-04-09 | 2007-06-05 | Evalve, Inc. | Fixation device delivery catheter, systems and methods of use |
US7604646B2 (en) | 1999-04-09 | 2009-10-20 | Evalve, Inc. | Locking mechanisms for fixation devices and methods of engaging tissue |
US7635329B2 (en) | 2004-09-27 | 2009-12-22 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
US7811296B2 (en) | 1999-04-09 | 2010-10-12 | Evalve, Inc. | Fixation devices for variation in engagement of tissue |
US8734505B2 (en) | 1999-04-09 | 2014-05-27 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US20180325671A1 (en) | 2017-05-12 | 2018-11-15 | Evalve, Inc. | Long arm valve repair clip |
US20200138567A1 (en) * | 2017-05-10 | 2020-05-07 | Edwards Lifesciences Corporation | Mitral valve spacer device |
WO2020176410A1 (en) * | 2019-02-25 | 2020-09-03 | Edwards Lifesciences Corporation | Heart valve sealing devices |
US20200315786A1 (en) * | 2017-09-07 | 2020-10-08 | Edwards Lifesciences Corporation | Prosthetic device for heart valve |
Family Cites Families (173)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3378010A (en) | 1965-07-28 | 1968-04-16 | Coldling | Surgical clip with means for releasing the clamping pressure |
US3874388A (en) | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
FR2306671A1 (en) | 1975-04-11 | 1976-11-05 | Rhone Poulenc Ind | VALVULAR IMPLANT |
US4340091A (en) | 1975-05-07 | 1982-07-20 | Albany International Corp. | Elastomeric sheet materials for heart valve and other prosthetic implants |
US4007743A (en) | 1975-10-20 | 1977-02-15 | American Hospital Supply Corporation | Opening mechanism for umbrella-like intravascular shunt defect closure device |
US4327736A (en) | 1979-11-20 | 1982-05-04 | Kanji Inoue | Balloon catheter |
US4657024A (en) | 1980-02-04 | 1987-04-14 | Teleflex Incorporated | Medical-surgical catheter |
US4809695A (en) | 1981-10-21 | 1989-03-07 | Owen M. Gwathmey | Suturing assembly and method |
US4693248A (en) | 1983-06-20 | 1987-09-15 | Ethicon, Inc. | Two-piece tissue fastener with deformable retaining receiver |
US4716886A (en) | 1986-05-01 | 1988-01-05 | Norman Schulman | Umbilical cord clamp and cutters |
US5125895A (en) | 1986-07-22 | 1992-06-30 | Medtronic Versaflex, Inc. | Steerable catheter |
US5478353A (en) | 1987-05-14 | 1995-12-26 | Yoon; Inbae | Suture tie device system and method for suturing anatomical tissue proximate an opening |
US5542949A (en) | 1987-05-14 | 1996-08-06 | Yoon; Inbae | Multifunctional clip applier instrument |
US4795458A (en) | 1987-07-02 | 1989-01-03 | Regan Barrie F | Stent for use following balloon angioplasty |
US5002562A (en) | 1988-06-03 | 1991-03-26 | Oberlander Michael A | Surgical clip |
WO1989009029A1 (en) | 1989-02-16 | 1989-10-05 | Taheri Syde A | Method and apparatus for removing venous valves |
US4930674A (en) | 1989-02-24 | 1990-06-05 | Abiomed, Inc. | Surgical stapler |
US5092872A (en) | 1989-07-28 | 1992-03-03 | Jacob Segalowitz | Valvulotome catheter |
EP0474887B1 (en) | 1990-04-02 | 1994-06-15 | Kanji Inoue | Device for closing shunt opening by nonoperative method |
US5098440A (en) | 1990-08-14 | 1992-03-24 | Cordis Corporation | Object retrieval method and apparatus |
US5389102A (en) | 1990-09-13 | 1995-02-14 | United States Surgical Corporation | Apparatus and method for subcuticular stapling of body tissue |
US5611794A (en) | 1990-10-11 | 1997-03-18 | Lasersurge, Inc. | Clamp for approximating tissue sections |
US5222963A (en) | 1991-01-17 | 1993-06-29 | Ethicon, Inc. | Pull-through circular anastomosic intraluminal stapler with absorbable fastener means |
US5163955A (en) | 1991-01-24 | 1992-11-17 | Autogenics | Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment |
US5330501A (en) | 1991-05-30 | 1994-07-19 | United States Surgical Corporation | Tissue gripping device for use with a cannula and a cannula incorporating the device |
US5147370A (en) | 1991-06-12 | 1992-09-15 | Mcnamara Thomas O | Nitinol stent for hollow body conduits |
GR920100358A (en) | 1991-08-23 | 1993-06-07 | Ethicon Inc | Surgical anastomosis stapling instrument. |
CA2082090C (en) | 1991-11-05 | 2004-04-27 | Jack Fagan | Improved occluder for repair of cardiac and vascular defects |
US5363861A (en) | 1991-11-08 | 1994-11-15 | Ep Technologies, Inc. | Electrode tip assembly with variable resistance to bending |
DE69324239T2 (en) | 1992-01-21 | 1999-11-04 | The Regents Of The University Of Minnesota, Minneapolis | SEPTUAL DAMAGE CLOSURE DEVICE |
US5327905A (en) | 1992-02-14 | 1994-07-12 | Boaz Avitall | Biplanar deflectable catheter for arrhythmogenic tissue ablation |
US5782239A (en) | 1992-06-30 | 1998-07-21 | Cordis Webster, Inc. | Unique electrode configurations for cardiovascular electrode catheter with built-in deflection method and central puller wire |
US6048351A (en) | 1992-09-04 | 2000-04-11 | Scimed Life Systems, Inc. | Transvaginal suturing system |
US5342373A (en) | 1992-09-14 | 1994-08-30 | Ethicon, Inc. | Sterile clips and instrument for their placement |
US5601224A (en) | 1992-10-09 | 1997-02-11 | Ethicon, Inc. | Surgical instrument |
US5814097A (en) | 1992-12-03 | 1998-09-29 | Heartport, Inc. | Devices and methods for intracardiac procedures |
US5403326A (en) | 1993-02-01 | 1995-04-04 | The Regents Of The University Of California | Method for performing a gastric wrap of the esophagus for use in the treatment of esophageal reflux |
US5797960A (en) | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
US6346074B1 (en) | 1993-02-22 | 2002-02-12 | Heartport, Inc. | Devices for less invasive intracardiac interventions |
AU6236794A (en) | 1993-02-22 | 1994-09-14 | Valleylab, Inc. | A laparoscopic dissection tension retractor device and method |
US5389077A (en) | 1993-03-03 | 1995-02-14 | Uresil Corporation | Minimally invasive body cavity penetrating instruments |
US5636634A (en) | 1993-03-16 | 1997-06-10 | Ep Technologies, Inc. | Systems using guide sheaths for introducing, deploying, and stabilizing cardiac mapping and ablation probes |
NL9300572A (en) | 1993-03-31 | 1994-10-17 | Cordis Europ | Method for manufacturing an extrusion profile with length-varying properties and catheter manufactured therewith. |
US5456400A (en) | 1993-04-22 | 1995-10-10 | United States Surgical Corporation | Apparatus and clip for fastening body tissue |
FR2708458B1 (en) | 1993-08-03 | 1995-09-15 | Seguin Jacques | Prosthetic ring for cardiac surgery. |
US5450860A (en) | 1993-08-31 | 1995-09-19 | W. L. Gore & Associates, Inc. | Device for tissue repair and method for employing same |
US5607462A (en) | 1993-09-24 | 1997-03-04 | Cardiac Pathways Corporation | Catheter assembly, catheter and multi-catheter introducer for use therewith |
US5452837A (en) | 1994-01-21 | 1995-09-26 | Ethicon Endo-Surgery, Inc. | Surgical stapler with tissue gripping ridge |
US5609598A (en) | 1994-12-30 | 1997-03-11 | Vnus Medical Technologies, Inc. | Method and apparatus for minimally invasive treatment of chronic venous insufficiency |
US5976159A (en) | 1995-02-24 | 1999-11-02 | Heartport, Inc. | Surgical clips and methods for tissue approximation |
US5695504A (en) | 1995-02-24 | 1997-12-09 | Heartport, Inc. | Devices and methods for performing a vascular anastomosis |
US5695505A (en) | 1995-03-09 | 1997-12-09 | Yoon; Inbae | Multifunctional spring clips and cartridges and applicators therefor |
US5562678A (en) | 1995-06-02 | 1996-10-08 | Cook Pacemaker Corporation | Needle's eye snare |
US5716417A (en) | 1995-06-07 | 1998-02-10 | St. Jude Medical, Inc. | Integral supporting structure for bioprosthetic heart valve |
US6117144A (en) | 1995-08-24 | 2000-09-12 | Sutura, Inc. | Suturing device and method for sealing an opening in a blood vessel or other biological structure |
US6015417A (en) | 1996-01-25 | 2000-01-18 | Reynolds, Jr.; Walker | Surgical fastener |
US5860992A (en) | 1996-01-31 | 1999-01-19 | Heartport, Inc. | Endoscopic suturing devices and methods |
US6182664B1 (en) | 1996-02-19 | 2001-02-06 | Edwards Lifesciences Corporation | Minimally invasive cardiac valve surgery procedure |
US5843178A (en) | 1996-06-20 | 1998-12-01 | St. Jude Medical, Inc. | Suture guard for annuloplasty ring |
US5855601A (en) | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
AU4082497A (en) | 1996-08-22 | 1998-03-06 | Trustees Of Columbia University, The | Endovascular flexible stapling device |
US5741297A (en) | 1996-08-28 | 1998-04-21 | Simon; Morris | Daisy occluder and method for septal defect repair |
US5713911A (en) | 1996-10-03 | 1998-02-03 | United States Surgical Corporation | Surgical clip |
US5755778A (en) | 1996-10-16 | 1998-05-26 | Nitinol Medical Technologies, Inc. | Anastomosis device |
US6332880B1 (en) | 1996-12-19 | 2001-12-25 | Ep Technologies, Inc. | Loop structures for supporting multiple electrode elements |
EP0850607A1 (en) | 1996-12-31 | 1998-07-01 | Cordis Corporation | Valve prosthesis for implantation in body channels |
US6149658A (en) | 1997-01-09 | 2000-11-21 | Coalescent Surgical, Inc. | Sutured staple surgical fasteners, instruments and methods for minimally invasive vascular and endoscopic surgery |
US6269819B1 (en) | 1997-06-27 | 2001-08-07 | The Trustees Of Columbia University In The City Of New York | Method and apparatus for circulatory valve repair |
IL121316A (en) | 1997-07-15 | 2001-07-24 | Litana Ltd | Implantable medical device of shape memory alloy |
DE69833665T2 (en) | 1997-08-08 | 2006-11-09 | Duke University | COMPOSITIONS FOR SIMPLIFYING SURGICAL PROCEDURES |
FR2768324B1 (en) | 1997-09-12 | 1999-12-10 | Jacques Seguin | SURGICAL INSTRUMENT FOR PERCUTANEOUSLY FIXING TWO AREAS OF SOFT TISSUE, NORMALLY MUTUALLY REMOTE, TO ONE ANOTHER |
FR2768325B1 (en) | 1997-09-16 | 1999-11-19 | Instr Medecine Veterinaire | CATHETER FOR ARTIFICIAL INSEMINATION OF BIRDS, ESPECIALLY TURKEYS, AND METHOD FOR PRODUCING SUCH A CATHETER |
WO1999015223A1 (en) | 1997-09-26 | 1999-04-01 | Cardeon Corporation | Multi-function aortic catheterization and bumper instrument |
US6120496A (en) | 1998-05-05 | 2000-09-19 | Scimed Life Systems, Inc. | Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and coupling device for use with same |
US6200315B1 (en) | 1997-12-18 | 2001-03-13 | Medtronic, Inc. | Left atrium ablation catheter |
US6193734B1 (en) | 1998-01-23 | 2001-02-27 | Heartport, Inc. | System for performing vascular anastomoses |
US6599311B1 (en) | 1998-06-05 | 2003-07-29 | Broncus Technologies, Inc. | Method and assembly for lung volume reduction |
US7569062B1 (en) | 1998-07-15 | 2009-08-04 | St. Jude Medical, Inc. | Mitral and tricuspid valve repair |
US6165183A (en) | 1998-07-15 | 2000-12-26 | St. Jude Medical, Inc. | Mitral and tricuspid valve repair |
US7972323B1 (en) | 1998-10-02 | 2011-07-05 | Boston Scientific Scimed, Inc. | Steerable device for introducing diagnostic and therapeutic apparatus into the body |
US6544215B1 (en) | 1998-10-02 | 2003-04-08 | Scimed Life Systems, Inc. | Steerable device for introducing diagnostic and therapeutic apparatus into the body |
US6217528B1 (en) | 1999-02-11 | 2001-04-17 | Scimed Life Systems, Inc. | Loop structure having improved tissue contact capability |
US6064600A (en) | 1999-03-01 | 2000-05-16 | Micron Technology, Inc. | Methods and apparatus for reading memory device register data |
US8118822B2 (en) | 1999-03-01 | 2012-02-21 | Medtronic, Inc. | Bridge clip tissue connector apparatus and methods |
US20040044350A1 (en) | 1999-04-09 | 2004-03-04 | Evalve, Inc. | Steerable access sheath and methods of use |
US10327743B2 (en) | 1999-04-09 | 2019-06-25 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
US6752813B2 (en) | 1999-04-09 | 2004-06-22 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
US8216256B2 (en) | 1999-04-09 | 2012-07-10 | Evalve, Inc. | Detachment mechanism for implantable fixation devices |
EP1198213B1 (en) | 1999-06-25 | 2010-06-09 | Vahid Saadat | Apparatus for treating tissue |
US6231561B1 (en) | 1999-09-20 | 2001-05-15 | Appriva Medical, Inc. | Method and apparatus for closing a body lumen |
US6312447B1 (en) | 1999-10-13 | 2001-11-06 | The General Hospital Corporation | Devices and methods for percutaneous mitral valve repair |
US6626930B1 (en) | 1999-10-21 | 2003-09-30 | Edwards Lifesciences Corporation | Minimally invasive mitral valve repair method and apparatus |
US6551303B1 (en) | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6926730B1 (en) | 2000-10-10 | 2005-08-09 | Medtronic, Inc. | Minimally invasive valve repair procedure and apparatus |
US6797002B2 (en) | 2000-02-02 | 2004-09-28 | Paul A. Spence | Heart valve repair apparatus and methods |
US6419696B1 (en) | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
SE0002878D0 (en) | 2000-08-11 | 2000-08-11 | Kimblad Ola | Device and method of treatment of atrioventricular regurgitation |
US20020107531A1 (en) | 2001-02-06 | 2002-08-08 | Schreck Stefan G. | Method and system for tissue repair using dual catheters |
EP1383448B1 (en) | 2001-03-29 | 2008-06-04 | Viacor, Inc. | Apparatus for improving mitral valve function |
US6837867B2 (en) | 2001-04-30 | 2005-01-04 | Biosense Webster, Inc. | Steerable catheter with reinforced tip |
US7338514B2 (en) | 2001-06-01 | 2008-03-04 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods and tools, and related methods of use |
DE60225303T2 (en) | 2001-08-31 | 2009-02-26 | Mitral Interventions, Redwood City | DEVICE FOR A HEART LAPSE REPAIR |
US6575971B2 (en) | 2001-11-15 | 2003-06-10 | Quantum Cor, Inc. | Cardiac valve leaflet stapler device and methods thereof |
US6978176B2 (en) | 2001-12-08 | 2005-12-20 | Lattouf Omar M | Treatment for patient with congestive heart failure |
US7048754B2 (en) | 2002-03-01 | 2006-05-23 | Evalve, Inc. | Suture fasteners and methods of use |
US6855137B2 (en) | 2002-03-07 | 2005-02-15 | Visionary Biomedical, Inc. | Catheter shaft with coextruded stiffener |
US7101395B2 (en) | 2002-06-12 | 2006-09-05 | Mitral Interventions, Inc. | Method and apparatus for tissue connection |
US20040034365A1 (en) | 2002-08-16 | 2004-02-19 | Lentz David J. | Catheter having articulation system |
US7556632B2 (en) | 2004-07-09 | 2009-07-07 | Reza Zadno | Device and method for repairing tissue |
AU2006212750B2 (en) | 2005-02-07 | 2011-11-17 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
US10076327B2 (en) | 2010-09-14 | 2018-09-18 | Evalve, Inc. | Flexible actuator mandrel for tissue apposition systems |
US9011468B2 (en) * | 2011-09-13 | 2015-04-21 | Abbott Cardiovascular Systems Inc. | Independent gripper |
US8945177B2 (en) * | 2011-09-13 | 2015-02-03 | Abbott Cardiovascular Systems Inc. | Gripper pusher mechanism for tissue apposition systems |
US10624664B2 (en) | 2011-09-28 | 2020-04-21 | Evalve, Inc. | Apparatuses and methods for cutting a tissue bridge and/or removing a heart valve clip or suture |
US20150112210A1 (en) | 2013-10-17 | 2015-04-23 | Abbott Cardiovascular Systems Inc. | Lumen based pressure measurement guide wire system for measuring pressure in a body lumen |
US10390943B2 (en) | 2014-03-17 | 2019-08-27 | Evalve, Inc. | Double orifice device for transcatheter mitral valve replacement |
US9572666B2 (en) | 2014-03-17 | 2017-02-21 | Evalve, Inc. | Mitral valve fixation device removal devices and methods |
CN111437068B (en) | 2014-12-04 | 2023-01-17 | 爱德华兹生命科学公司 | Percutaneous clamp for repairing heart valve |
US10188392B2 (en) * | 2014-12-19 | 2019-01-29 | Abbott Cardiovascular Systems, Inc. | Grasping for tissue repair |
US10524912B2 (en) | 2015-04-02 | 2020-01-07 | Abbott Cardiovascular Systems, Inc. | Tissue fixation devices and methods |
US9827122B2 (en) | 2015-05-04 | 2017-11-28 | Abbott Cardiovascular Systems Inc. | System for a catheter |
WO2016183485A1 (en) | 2015-05-14 | 2016-11-17 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US10376673B2 (en) | 2015-06-19 | 2019-08-13 | Evalve, Inc. | Catheter guiding system and methods |
US10238494B2 (en) | 2015-06-29 | 2019-03-26 | Evalve, Inc. | Self-aligning radiopaque ring |
US10667815B2 (en) | 2015-07-21 | 2020-06-02 | Evalve, Inc. | Tissue grasping devices and related methods |
US10413408B2 (en) | 2015-08-06 | 2019-09-17 | Evalve, Inc. | Delivery catheter systems, methods, and devices |
USD816832S1 (en) | 2015-10-09 | 2018-05-01 | Evalve, Inc. | Stabilizer |
US10226309B2 (en) | 2015-10-09 | 2019-03-12 | Evalve, Inc. | Devices, systems, and methods to support, stabilize, and position a medical device |
USD809139S1 (en) | 2015-10-09 | 2018-01-30 | Evalve, Inc. | Handle for a medical device |
US10238495B2 (en) | 2015-10-09 | 2019-03-26 | Evalve, Inc. | Delivery catheter handle and methods of use |
US10299924B2 (en) | 2016-02-10 | 2019-05-28 | Abbott Cardiovascular Systems Inc. | System and method for implant delivery |
US10398549B2 (en) | 2016-03-15 | 2019-09-03 | Abbott Cardiovascular Systems Inc. | System and method for transcatheter heart valve platform |
EP3471628B8 (en) | 2016-06-20 | 2021-04-21 | Evalve, Inc. | Transapical removal device |
US10736632B2 (en) | 2016-07-06 | 2020-08-11 | Evalve, Inc. | Methods and devices for valve clip excision |
US10058426B2 (en) | 2016-07-20 | 2018-08-28 | Abbott Cardiovascular Systems Inc. | System for tricuspid valve repair |
US10478304B2 (en) | 2016-07-20 | 2019-11-19 | Abbott Cardiovascular Systems Inc. | Independent system for tricuspid valve repair |
EP3490444B1 (en) | 2016-07-28 | 2023-06-07 | Evalve, Inc. | Systems and methods for intra-procedural cardiac pressure monitoring |
US10945842B2 (en) | 2016-08-04 | 2021-03-16 | Evalve, Inc. | Annular augmentation device for cardiac valve repair |
US11071564B2 (en) | 2016-10-05 | 2021-07-27 | Evalve, Inc. | Cardiac valve cutting device |
US10363138B2 (en) | 2016-11-09 | 2019-07-30 | Evalve, Inc. | Devices for adjusting the curvature of cardiac valve structures |
US10398553B2 (en) | 2016-11-11 | 2019-09-03 | Evalve, Inc. | Opposing disk device for grasping cardiac valve tissue |
US10398552B2 (en) | 2016-11-15 | 2019-09-03 | Abbott Cardiovascular Systems Inc. | Fixation devices, systems and methods for heart valve leaf repair |
US10426616B2 (en) | 2016-11-17 | 2019-10-01 | Evalve, Inc. | Cardiac implant delivery system |
US10420565B2 (en) | 2016-11-29 | 2019-09-24 | Abbott Cardiovascular Systems Inc. | Cinch and post for tricuspid valve repair |
US10548614B2 (en) * | 2016-11-29 | 2020-02-04 | Evalve, Inc. | Tricuspid valve repair system |
US10779837B2 (en) | 2016-12-08 | 2020-09-22 | Evalve, Inc. | Adjustable arm device for grasping tissues |
US10314586B2 (en) | 2016-12-13 | 2019-06-11 | Evalve, Inc. | Rotatable device and method for fixing tricuspid valve tissue |
US10675439B2 (en) | 2017-02-21 | 2020-06-09 | Abbott Cardiovascular Systems Inc. | High torsion delivery catheter element |
US10952852B2 (en) | 2017-02-24 | 2021-03-23 | Abbott Cardiovascular Systems Inc. | Double basket assembly for valve repair |
US10149685B2 (en) | 2017-02-28 | 2018-12-11 | Abbott Cardiovascular Systems Inc. | System and method for mitral valve function |
ES2906137T3 (en) * | 2017-04-18 | 2022-04-13 | Edwards Lifesciences Corp | Heart valve sealing devices and delivery devices therefor |
US10517598B2 (en) | 2017-06-07 | 2019-12-31 | Evalve, Inc. | Tissue tensioning device for cardiac valve repair |
US10779829B2 (en) | 2017-06-07 | 2020-09-22 | Evalve, Inc. | Tissue compression device for cardiac valve repair |
US20190030285A1 (en) | 2017-07-27 | 2019-01-31 | Evalve, Inc. | Intravascular delivery system with centralized steering |
US10646343B2 (en) | 2017-10-27 | 2020-05-12 | Abbott Cardiovascular Systems Inc. | System and method for valve activation |
WO2019089627A1 (en) | 2017-10-30 | 2019-05-09 | Cephea Valve Technologies, Inc. | Insert for distal end cap |
US10856985B2 (en) | 2017-11-21 | 2020-12-08 | Abbott Cardiovascular Systems Inc. | System and method for annuloplasty |
US10136993B1 (en) | 2018-01-09 | 2018-11-27 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10076415B1 (en) | 2018-01-09 | 2018-09-18 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10159570B1 (en) | 2018-01-09 | 2018-12-25 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10105222B1 (en) | 2018-01-09 | 2018-10-23 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10123873B1 (en) | 2018-01-09 | 2018-11-13 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10245144B1 (en) | 2018-01-09 | 2019-04-02 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10130475B1 (en) | 2018-01-09 | 2018-11-20 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10111751B1 (en) * | 2018-01-09 | 2018-10-30 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10231837B1 (en) | 2018-01-09 | 2019-03-19 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10973639B2 (en) | 2018-01-09 | 2021-04-13 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10507109B2 (en) | 2018-01-09 | 2019-12-17 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10238493B1 (en) | 2018-01-09 | 2019-03-26 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US11207181B2 (en) * | 2018-04-18 | 2021-12-28 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US10945844B2 (en) | 2018-10-10 | 2021-03-16 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US12102531B2 (en) | 2018-10-22 | 2024-10-01 | Evalve, Inc. | Tissue cutting systems, devices and methods |
WO2020237176A1 (en) | 2019-05-22 | 2020-11-26 | Evalve, Inc. | Devices and systems for accessing and repairing a heart valve |
-
2021
- 2021-09-24 US US17/484,203 patent/US12121439B2/en active Active
- 2021-09-24 EP EP21791562.8A patent/EP4196054A1/en active Pending
- 2021-09-24 WO PCT/US2021/051923 patent/WO2022081328A1/en unknown
-
2024
- 2024-09-20 US US18/890,903 patent/US20250009511A1/en active Pending
Patent Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8303608B2 (en) | 1999-04-09 | 2012-11-06 | Evalve, Inc. | Fixation devices for variation in engagement of tissue |
US8734505B2 (en) | 1999-04-09 | 2014-05-27 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US7604646B2 (en) | 1999-04-09 | 2009-10-20 | Evalve, Inc. | Locking mechanisms for fixation devices and methods of engaging tissue |
US8500761B2 (en) | 1999-04-09 | 2013-08-06 | Abbott Vascular | Fixation devices, systems and methods for engaging tissue |
US7655015B2 (en) | 1999-04-09 | 2010-02-02 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US7736388B2 (en) | 1999-04-09 | 2010-06-15 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US7811296B2 (en) | 1999-04-09 | 2010-10-12 | Evalve, Inc. | Fixation devices for variation in engagement of tissue |
US8057493B2 (en) | 1999-04-09 | 2011-11-15 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US7563267B2 (en) | 1999-04-09 | 2009-07-21 | Evalve, Inc. | Fixation device and methods for engaging tissue |
US7226467B2 (en) | 1999-04-09 | 2007-06-05 | Evalve, Inc. | Fixation device delivery catheter, systems and methods of use |
US20170239048A1 (en) | 1999-04-09 | 2017-08-24 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US8740920B2 (en) | 1999-04-09 | 2014-06-03 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US9510829B2 (en) | 1999-04-09 | 2016-12-06 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US20170042546A1 (en) | 1999-04-09 | 2017-02-16 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US7635329B2 (en) | 2004-09-27 | 2009-12-22 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
US20200138567A1 (en) * | 2017-05-10 | 2020-05-07 | Edwards Lifesciences Corporation | Mitral valve spacer device |
US20180325671A1 (en) | 2017-05-12 | 2018-11-15 | Evalve, Inc. | Long arm valve repair clip |
US20200315786A1 (en) * | 2017-09-07 | 2020-10-08 | Edwards Lifesciences Corporation | Prosthetic device for heart valve |
WO2020176410A1 (en) * | 2019-02-25 | 2020-09-03 | Edwards Lifesciences Corporation | Heart valve sealing devices |
Also Published As
Publication number | Publication date |
---|---|
EP4196054A1 (en) | 2023-06-21 |
US12121439B2 (en) | 2024-10-22 |
US20250009511A1 (en) | 2025-01-09 |
US20220117737A1 (en) | 2022-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20250000654A1 (en) | Wide Clip With Deformable Width | |
US11998449B2 (en) | Repair clip for variable tissue thickness | |
US12029425B2 (en) | Independent gripper | |
US20240074854A1 (en) | Proximal Element Actuator Fixation And Release Mechanisms | |
EP1176913B1 (en) | Methods and apparatus for cardiac valve repair | |
JP5371440B2 (en) | Papillary muscle position control device, system and method | |
CN113301869A (en) | Heart valve sealing device, delivery device and retrieval device thereof | |
EP3541295A1 (en) | Fixation devices, systems and methods for heart valve leaf repair | |
US12178704B2 (en) | Wide clip with nondeformable wings | |
US20250009511A1 (en) | Biased Distal Assemblies With Locking Mechanism | |
CN113796990A (en) | Valve presss from both sides with locking mechanism | |
CN118785871A (en) | Heart valve repair device | |
CN214511424U (en) | Valve presss from both sides with locking mechanism | |
CN216439372U (en) | Self-adaptive valve clamping device and valve clamping system | |
CN114681143B (en) | An adaptive valve clamping device and valve clamping system | |
EP4280972A1 (en) | Minimally invasive heart valve repair in a beating heart | |
US20240164896A1 (en) | Tunable Fixation Device | |
US11801140B2 (en) | Catheter assembly with coaptation aid and methods for valve repair | |
US11654024B1 (en) | Heart valve clip | |
WO2024108118A1 (en) | Fixation device with symmetrical extension elements |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21791562 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2021791562 Country of ref document: EP Effective date: 20230316 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |